GammaGard Liquid recalled

The FDA and Baxter BioScience have notified healthcare professionals of a voluntary recall being conducted as a precautionary measure due to an increased number of adverse event reports of allergic reactions associated with two lots of GammaGard Liquid (immune globulin intravenous [human]). The two lots being withdrawn are:
  • Lot #: LE12J370AB; Product code: 1500185; NDC #: 0944-2700-06; Expiration date: November 21, 2012
  • Lot #: LE12J379AB; Product code: 1500187; NDC #: 0944-2700-05; Expiration date: November 29, 2012
GammaGard is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity.

For more information visit www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm214497.htm.